| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Jerome W Breslin | |
| Walter N Durán | |||
| Fabiola A Sánchez | |||
| P2860 | cites work | Regulation of endothelium-derived nitric oxide production by the protein kinase Akt | Q22010149 |
| Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation | Q22010150 | ||
| The first 35 amino acids and fatty acylation sites determine the molecular targeting of endothelial nitric oxide synthase into the Golgi region of cells: a green fluorescent protein study | Q24680049 | ||
| The regulation and pharmacology of endothelial nitric oxide synthase | Q28290711 | ||
| Ca(2+) signalling and PKCalpha activate increased endothelial permeability by disassembly of VE-cadherin junctions | Q28366225 | ||
| Endothelial [Ca2+]i and caveolin-1 antagonistically regulate eNOS activity and microvessel permeability in rat venules | Q28396604 | ||
| Novel mechanism of endothelial nitric oxide synthase activation mediated by caveolae internalization in endothelial cells | Q28573836 | ||
| Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: implications for nitric oxide signaling | Q28609890 | ||
| Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the nos caveolin binding domain in vivo | Q28609900 | ||
| The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine | Q29547539 | ||
| Molecular cloning and expression of a cDNA encoding endothelial cell nitric oxide synthase | Q30311435 | ||
| Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform | Q30990194 | ||
| Phosphorylation of Thr(495) regulates Ca(2+)/calmodulin-dependent endothelial nitric oxide synthase activity. | Q33950554 | ||
| Involvement of PKCdelta and PKD in pulmonary microvascular endothelial cell hyperpermeability | Q44588542 | ||
| Role of neutral amino acid transport and protein breakdown for substrate supply of nitric oxide synthase in human endothelial cells. | Q44598355 | ||
| Phorbol ester-mediated pulmonary artery endothelial barrier dysfunction through regulation of actin cytoskeletal mechanics | Q44788536 | ||
| Nitric oxide-dependent allosteric inhibitory role of a second nucleotide binding site in soluble guanylyl cyclase | Q45223552 | ||
| Differences in eNOS activity because of subcellular localization are dictated by phosphorylation state rather than the local calcium environment. | Q46781614 | ||
| Epac/Rap1 pathway regulates microvascular hyperpermeability induced by PAF in rat mesentery | Q46790204 | ||
| Functional relevance of Golgi- and plasma membrane-localized endothelial NO synthase in reconstituted endothelial cells | Q46973331 | ||
| Shear stress affects the intracellular distribution of eNOS: direct demonstration by a novel in vivo technique. | Q50758193 | ||
| Role of protein kinase C in bradykinin-induced increases in microvascular permeability | Q67687831 | ||
| Role of nitric oxide in modulating permeability of hamster cheek pouch in response to adenosine 5'-diphosphate and bradykinin | Q68046905 | ||
| Acute microcirculatory effects of platelet-activating factor | Q68397625 | ||
| Mechanisms for redistribution of plasma protein following acute protein depletion | Q70502369 | ||
| Histamine increases venular permeability via a phospholipase C-NO synthase-guanylate cyclase cascade | Q72081566 | ||
| Inhibition of nitric oxide production. Mechanisms of vascular albumin leakage | Q72083095 | ||
| Platelet-activating factor modulates microvascular transport by stimulation of protein kinase C | Q72370029 | ||
| ECV304 (endothelial) is really T24 (bladder carcinoma): cell line cross- contamination at source | Q73310639 | ||
| Platelet-activating factor modulates microvascular dynamics through phospholipase C in the hamster cheek pouch | Q73334211 | ||
| A chimeric transmembrane domain directs endothelial nitric-oxide synthase palmitoylation and targeting to plasmalemmal caveolae | Q73728367 | ||
| Endotoxin-induced mesenteric microvascular changes involve iNOS-derived nitric oxide: results from a study using iNOS knock out mice | Q73780942 | ||
| VEGF increases permeability of the endothelial cell monolayer by activation of PKB/akt, endothelial nitric-oxide synthase, and MAP kinase pathways | Q77066652 | ||
| Role of phospholipase C, protein kinase C, and calcium in VEGF-induced venular hyperpermeability | Q78020315 | ||
| Epac1 regulates integrity of endothelial cell junctions through VE-cadherin | Q81098205 | ||
| Endothelial nitric oxide synthase regulates microvascular hyperpermeability in vivo | Q83289004 | ||
| Signal transduction pathways in enhanced microvascular permeability | Q34120929 | ||
| Adhesion molecules and their role in vascular disease | Q34285554 | ||
| Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability | Q34478521 | ||
| Functional significance of hsp90 complexes with NOS and sGC in endothelial cells | Q34653954 | ||
| Estradiol induces the calcium-dependent translocation of endothelial nitric oxide synthase. | Q35060761 | ||
| Functional significance of differential eNOS translocation. | Q35119063 | ||
| Nitric oxide synthase generates nitric oxide locally to regulate compartmentalized protein S-nitrosylation and protein trafficking | Q35544395 | ||
| eNOS at a glance | Q35782010 | ||
| Desensitization of soluble guanylyl cyclase, the NO receptor, by S-nitrosylation | Q35925811 | ||
| Cyclic AMP induces integrin-mediated cell adhesion through Epac and Rap1 upon stimulation of the beta 2-adrenergic receptor | Q36324985 | ||
| Phosphorylation and subcellular translocation of endothelial nitric oxide synthase | Q36402798 | ||
| Microvascular permeability in diabetes and insulin resistance | Q36871773 | ||
| Heat shock protein 90 inhibitors protect and restore pulmonary endothelial barrier function | Q36951836 | ||
| Internalization of eNOS via caveolae regulates PAF-induced inflammatory hyperpermeability to macromolecules | Q36995182 | ||
| Internalization of eNOS and NO delivery to subcellular targets determine agonist-induced hyperpermeability | Q37167720 | ||
| Increased intraocular insulin-like growth factor-I triggers blood-retinal barrier breakdown | Q37371699 | ||
| Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells | Q37628594 | ||
| Platelet activating factor modulates microvascular permeability through nitric oxide synthesis | Q39417098 | ||
| Protein kinase C modulates microvascular permeability through nitric oxide synthase | Q39434580 | ||
| Vascular endothelial growth factor stimulates differential signaling pathways in in vivo microcirculation | Q39685561 | ||
| Phosphorylation of threonine 497 in endothelial nitric-oxide synthase coordinates the coupling of L-arginine metabolism to efficient nitric oxide production | Q40638231 | ||
| Localization of endothelial nitric-oxide synthase phosphorylated on serine 1179 and nitric oxide in Golgi and plasma membrane defines the existence of two pools of active enzyme. | Q40765690 | ||
| Leukocyte responses to injury | Q40779978 | ||
| Trafficking of endothelial nitric-oxide synthase in living cells. Quantitative evidence supporting the role of palmitoylation as a kinetic trapping mechanism limiting membrane diffusion. | Q40938612 | ||
| Capillary hydraulic conductivity is elevated by cGMP-dependent vasodilators | Q41082512 | ||
| Protein kinase C phosphorylates caldesmon77 and vimentin and enhances albumin permeability across cultured bovine pulmonary artery endothelial cell monolayers | Q41110801 | ||
| Palmitoylation of endothelial nitric oxide synthase is necessary for optimal stimulated release of nitric oxide: implications for caveolae localization | Q41158636 | ||
| Regulation of protein kinase C. | Q41382903 | ||
| Evidence that endogenous nitric oxide modulates oedema formation induced by substance P. | Q41773123 | ||
| Role of local production of endothelium-derived nitric oxide on cGMP signaling and S-nitrosylation. | Q41871145 | ||
| Flow modulates coronary venular permeability by a nitric oxide-related mechanism | Q42171428 | ||
| Interaction of PKC and NOS in signal transduction of microvascular hyperpermeability | Q42447296 | ||
| Functional characterization of nitric oxide and YC-1 activation of soluble guanylyl cyclase: structural implication for the YC-1 binding site? | Q42458596 | ||
| cGMP modulates basal and activated microvessel permeability independently of [Ca2+]i | Q42464888 | ||
| Regulation of vascular endothelial barrier function by Epac, a cAMP-activated exchange factor for Rap GTPase | Q42467728 | ||
| Receptor-regulated dynamic S-nitrosylation of endothelial nitric-oxide synthase in vascular endothelial cells | Q42475721 | ||
| Regulation of endothelial constitutive nitric oxide synthase by protein kinase C. | Q42477136 | ||
| Src kinase activates endothelial nitric-oxide synthase by phosphorylating Tyr-83. | Q42483154 | ||
| Regulation of endothelial cell gap formation and barrier dysfunction: role of myosin light chain phosphorylation | Q42486528 | ||
| Functional reconstitution of endothelial nitric oxide synthase reveals the importance of serine 1179 in endothelium-dependent vasomotion | Q42520896 | ||
| Nitroglycerin-induced S-nitrosylation and desensitization of soluble guanylyl cyclase contribute to nitrate tolerance | Q42544768 | ||
| Counter regulatory effects of PKCbetaII and PKCdelta on coronary endothelial permeability | Q43198819 | ||
| Nitric oxide modulates microvascular permeability | Q43591645 | ||
| p42/44MAPK regulates baseline permeability and cGMP-induced hyperpermeability in endothelial cells | Q43897447 | ||
| ACh-induced endothelial NO synthase translocation, NO release and vasodilatation in the hamster microcirculation in vivo. | Q44201753 | ||
| Effect of platelet-activating factor on microvascular permselectivity: dose-response relations and pathways of action in the hamster cheek pouch microcirculation | Q44493658 | ||
| P433 | issue | 2 | |
| P921 | main subject | microvessel | Q6840468 |
| P304 | page(s) | 254-261 | |
| P577 | publication date | 2010-05-11 | |
| P1433 | published in | Cardiovascular Research | Q4642329 |
| P1476 | title | The NO cascade, eNOS location, and microvascular permeability | |
| P478 | volume | 87 |
| Q28477019 | A novel compound C12 inhibits inflammatory cytokine production and protects from inflammatory injury in vivo |
| Q34266227 | Acute alcohol intoxication-induced microvascular leakage |
| Q38111810 | Assessing the functional properties of high-density lipoproteins: an emerging concept in cardiovascular research |
| Q36321578 | Bojesodok-eum, a Herbal Prescription, Ameliorates Acute Inflammation in Association with the Inhibition of NF-κB-Mediated Nitric Oxide and ProInflammatory Cytokine Production |
| Q45783250 | Bradykinin in health and disease: proceedings of the Bradykinin Symposium 2012, Berlin 23-24 August 2012. |
| Q37342170 | Caveolin-1 scaffolding domain promotes leukocyte adhesion by reduced basal endothelial nitric oxide-mediated ICAM-1 phosphorylation in rat mesenteric venules. |
| Q55122044 | Citrulline Improves Early Post-Ischemic Recovery or Rat Hearts In Vitro by Shifting Arginine Metabolism From Polyamine to Nitric Oxide Formation. |
| Q90227498 | Clostridium difficile toxins induce VEGF-A and vascular permeability to promote disease pathogenesis |
| Q41906283 | Coordinated endothelial nitric oxide synthase activation by translocation and phosphorylation determines flow-induced nitric oxide production in resistance vessels |
| Q47388142 | Cryptotanshinone exhibits therapeutical effects on cerebral stroke through the PI3K/AKT‑eNOS signaling pathway |
| Q42284817 | Current knowledge on the mechanism of atherosclerosis and pro-atherosclerotic properties of oxysterols |
| Q33625347 | Decreased expression of GST pi is correlated with a poor prognosis in human esophageal squamous carcinoma |
| Q37571635 | Demethoxycurcumin Preserves Renovascular Function by Downregulating COX-2 Expression in Hypertension. |
| Q36280060 | Dengue Virus-Induced Inflammation of the Endothelium and the Potential Roles of Sphingosine Kinase-1 and MicroRNAs. |
| Q36747218 | Disruption of endothelial cell mitochondrial bioenergetics in lambs with increased pulmonary blood flow |
| Q54989042 | Effect of rosuvastatin on the expression of candidate gene GALNT3 in atherosclerosis. |
| Q55334826 | Endothelial Mechanotransduction, Redox Signaling and the Regulation of Vascular Inflammatory Pathways. |
| Q58579165 | Endothelial Protrusions in Junctional Integrity and Barrier Function |
| Q43747274 | Endothelial Regulator of Calcineurin 1 Promotes Barrier Integrity and Modulates Histamine-Induced Barrier Dysfunction in Anaphylaxis. |
| Q38801310 | Endothelial cAMP deactivates ischemia-reperfusion-induced microvascular hyperpermeability via Rap1-mediated mechanisms. |
| Q50072965 | Endothelial nitric oxide synthase modulates Toll-like receptor 4-mediated IL-6 production and permeability via nitric oxide-independent signaling. |
| Q30406363 | Fatal outcome of pandemic H1N1 2009 influenza virus infection is associated with immunopathology and impaired lung repair, not enhanced viral burden, in pregnant mice |
| Q33994061 | GABAB receptors expressed in human aortic endothelial cells mediate intracellular calcium concentration regulation and endothelial nitric oxide synthase translocation |
| Q42962969 | High glucose enhances LPS-stimulated human PMVEC hyperpermeability via the NO pathway |
| Q54282706 | Hydrogen sulfide promotes nitric oxide production in corpus cavernosum by enhancing expression of endothelial nitric oxide synthase. |
| Q47299277 | Hypertension regulating angiotensin peptides in the pathobiology of cardiovascular disease. |
| Q37322755 | Inhibition of Acute Phase Inflammation by Laminaria japonica through Regulation of iNOS-NF- κ B Pathway |
| Q37071944 | Inhibition of endothelial nitric oxide synthase decreases breast cancer cell MDA-MB-231 adhesion to intact microvessels under physiological flows |
| Q35000486 | Innovations in studying in vivo cell behavior and pharmacology in complex tissues--microvascular endothelial cells in the spotlight. |
| Q37704798 | Interplay of myosin phosphatase and protein phosphatase-2A in the regulation of endothelial nitric-oxide synthase phosphorylation and nitric oxide production |
| Q38804579 | Lung Circulation |
| Q90482453 | Lymphatic Vessel Network Structure and Physiology |
| Q35812849 | Lymphatic vascular integrity is disrupted in type 2 diabetes due to impaired nitric oxide signalling |
| Q49831119 | Mechanisms Underlying Chronic Binge Alcohol Exposure-Induced Uterine Artery Dysfunction in Pregnant Rat. |
| Q28390079 | Metabolic actions of angiotensin II and insulin: a microvascular endothelial balancing act |
| Q36536592 | Methamphetamine-induced nitric oxide promotes vesicular transport in blood-brain barrier endothelial cells. |
| Q37285993 | Methanol Extract of Artemisia apiacea Hance Attenuates the Expression of Inflammatory Mediators via NF- κ B Inactivation |
| Q37076073 | Myosin light chain kinase signaling in endothelial barrier dysfunction |
| Q39102339 | Neutrophil-mediated vascular barrier injury: Role of neutrophil extracellular traps |
| Q30382612 | Nitric Oxide-Enhanced Molecular Imaging of Atheroma using Vascular Cellular Adhesion Molecule 1-Targeted Echogenic Immunoliposomes. |
| Q30423822 | Nitric oxide improves molecular imaging of inflammatory atheroma using targeted echogenic immunoliposomes |
| Q37887771 | Nitric oxide: a guardian for vascular grafts? |
| Q28290660 | Nonthermal electromagnetic fields: from first messenger to therapeutic applications |
| Q35206447 | PKC-dependent phosphorylation of eNOS at T495 regulates eNOS coupling and endothelial barrier function in response to G+ -toxins |
| Q64093273 | Paroxysmal Permeability Disorders: Development of a Microfluidic Device to Assess Endothelial Barrier Function |
| Q35006019 | Platelet activating factor-induced ceramide micro-domains drive endothelial NOS activation and contribute to barrier dysfunction |
| Q35081129 | Protein kinase C inhibition ameliorates functional endothelial insulin resistance and vascular smooth muscle cell hypersensitivity to insulin in diabetic hypertensive rats |
| Q36932174 | Protein kinase G oxidation is a major cause of injury during sepsis. |
| Q58051346 | Reduction of angiotensin A and alamandine vasoactivity in the rabbit model of atherogenesis: differential effects of alamandine and Ang(1-7) |
| Q35757774 | Resveratrol supplementation abrogates pro-arteriogenic effects of intramyocardial vascular endothelial growth factor in a hypercholesterolemic swine model of chronic ischemia |
| Q50318383 | RhoA S-nitrosylation as a regulatory mechanism influencing endothelial barrier function in response to G+-bacterial toxins. |
| Q35948515 | Role of reactive oxygen and nitrogen species in the vascular responses to inflammation |
| Q36902308 | S-nitrosylation regulates VE-cadherin phosphorylation and internalization in microvascular permeability |
| Q28388936 | Silica nanoparticles induce oxidative stress, inflammation, and endothelial dysfunction in vitro via activation of the MAPK/Nrf2 pathway and nuclear factor-κB signaling |
| Q46522841 | Tetramethylpyrazine Protects Against Oxygen-Glucose Deprivation-Induced Brain Microvascular Endothelial Cells Injury via Rho/Rho-kinase Signaling Pathway |
| Q47327822 | The relationship between lymphangion chain length and maximum pressure generation established through in vivo imaging and computational modeling |
| Q111271260 | The spike protein of SARS-CoV-2 induces endothelial inflammation through integrin α5β1 and NF-κB signaling |
| Q39966848 | Therapeutic Antibody-Induced Vascular Toxicity Due to Off-Target Activation of Nitric Oxide in Cynomolgus Monkeys. |
| Q33737304 | U-Bang-Haequi Tang: A Herbal Prescription that Prevents Acute Inflammation through Inhibition of NF-κB-Mediated Inducible Nitric Oxide Synthase |
| Q35067747 | Urokinase-type plasminogen activator (uPA) induces pulmonary microvascular endothelial permeability through low density lipoprotein receptor-related protein (LRP)-dependent activation of endothelial nitric-oxide synthase |
| Q30423029 | VEGFR2 induces c-Src signaling and vascular permeability in vivo via the adaptor protein TSAd. |
| Q41953856 | Vascular hypercontractility and endothelial dysfunction before development of atherosclerosis in moderate dyslipidemia: role for nitric oxide and interleukin-6. |
| Q37665350 | Vascular hyperpermeability and aging |
| Q39164918 | Vascular hyperpermeability as a hallmark of phacomatoses: is the etiology angiogenesis comparable with mechanisms seen in inflammatory pathways? Part I: historical observations and clinical perspectives on the etiology of increased CSF protein level |
| Q39173616 | Vascular hyperpermeability as a hallmark of phacomatoses: is the etiology angiogenesis related to or comparable with mechanisms seen in inflammatory pathways? Part II: angiogenesis- and inflammation-related molecular pathways, tumor-associated macro |
| Q33954964 | Vascular permeability modulation at the cell, microvessel, or whole organ level: towards closing gaps in our knowledge |
| Q38093079 | miR-221/222: promising biomarkers for breast cancer |
Search more.